Zentiva Pharma UK Ltd

Information

Name

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

Address

12 New Fetter Lane

london
EC4A 1JP
United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Zentiva Pharma UK Ltd
Sign up free

Contracts awarded to Zentiva Pharma UK Ltd

The contracts that Zentiva Pharma UK Ltd have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 4 weeks ago

NHS National Framework for the supply of Pomalidomide commencing 1 April 2025

Project title: NHS National Framework for the supply of Pomalidomide commencing 1 April 2025 Offer reference number: CM/TNS/24/5719 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5719/01 - Pomalidomide Lot 1 CESW: 01/04/2025 to 31/05/2026 Lot 2 LSNE: 01/04/2025 to 31/05/2026 Lot 3 NWLN: 01/04/2025 to 31/05/2026 Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

£5
Award

Published 4 weeks ago

CM/TNS/24/5719 - NHS National Framework for the supply of Pomalidomide

Project title: NHS National Framework for the supply of Pomalidomide commencing 1 April 2025 Offer reference number: CM/TNS/24/5719 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5719/01 - Pomalidomide Lot 1 CESW: 01/04/2025 to 31/05/2026 Lot 2 LSNE: 01/04/2025 to 31/05/2026 Lot 3 NWLN: 01/04/2025 to 31/05/2026 Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

£17,087,000 Bids close: 3 months ago
Award

Published 4 weeks ago

NHS National Framework for the supply of Pomalidomide commencing 1 April 2025

Project title: NHS National Framework for the supply of Pomalidomide commencing 1 April 2025 Offer reference number: CM/TNS/24/5719 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5719/01 - Pomalidomide Lot 1 CESW: 01/04/2025 to 31/05/2026 Lot 2 LSNE: 01/04/2025 to 31/05/2026 Lot 3 NWLN: 01/04/2025 to 31/05/2026 Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

£5
Award

Published 4 weeks ago

NHS National Framework for the supply of Pomalidomide commencing 1 April 2025

Project title: NHS National Framework for the supply of Pomalidomide commencing 1 April 2025 Offer reference number: CM/TNS/24/5719 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5719/01 - Pomalidomide Lot 1 CESW: 01/04/2025 to 31/05/2026 Lot 2 LSNE: 01/04/2025 to 31/05/2026 Lot 3 NWLN: 01/04/2025 to 31/05/2026 Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

£5
Award

Published 2 months ago

Generic, Branded Generic & Proprietary Medicinal Products - Group 15

Generic, Branded Generic & Proprietary Medicinal Products - Group 15 (5417226)

£10,593,948
Award

Published 2 months ago

CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025

Project title: NHS National Framework for Transition products commencing 1 February 2025 Offer reference number: CM/TNS/24/5713 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months) Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months) Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

£9,867,000 Bids close: 4 months ago

Contacts

+44 800854431

Statistics (1 Year)

Contracts Won

Total Won

£61,805,569

Average Win

£15,451,392

Zentiva Pharma UK Ltd

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Zentiva Pharma UK Ltd

NHS National Framework for the supply of Pomalidomide commencing 1 April 2025

CM/TNS/24/5719 - NHS National Framework for the supply of Pomalidomide

NHS National Framework for the supply of Pomalidomide commencing 1 April 2025

NHS National Framework for the supply of Pomalidomide commencing 1 April 2025

Generic, Branded Generic & Proprietary Medicinal Products - Group 15

CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win